A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

F. Lanza; F. Saraceni; A. Pezzi; M. Martino; A. Bosi; N. Cascavilla; P. Musto; E. Zuffa; M. Tani; C. Cellini; D. Laszlo; F. Bonifazi; on behalf of GITMO (Italian Society for Transplantation)

doi:10.1002/ajh.24817

A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

F. Lanza, F. Saraceni, A. Pezzi, M. Martino, A. Bosi, N. Cascavilla, P. Musto, E. Zuffa, M. Tani, C. Cellini, D. Laszlo, F. Bonifazi, on behalf of GITMO (Italian Society for Transplantation)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	E557-E559
Journal	American Journal of Hematology
Volume	92
Issue number	9
DOIs	https://doi.org/10.1002/ajh.24817
Publication status	Published - 2017

Access to Document

10.1002/ajh.24817

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85025455996&doi=10.1002%2fajh.24817&partnerID=40&md5=1a9ca7294204eaf4cbf5e0e1ffd530d3

Cite this

Lanza, F., Saraceni, F., Pezzi, A., Martino, M., Bosi, A., Cascavilla, N., Musto, P., Zuffa, E., Tani, M., Cellini, C., Laszlo, D., Bonifazi, F., & Transplantation), O. B. O. GITMO. (2017). A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach. American Journal of Hematology, 92(9), E557-E559. https://doi.org/10.1002/ajh.24817

A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach. / Lanza, F.; Saraceni, F.; Pezzi, A. et al.

In: American Journal of Hematology, Vol. 92, No. 9, 2017, p. E557-E559.

Research output: Contribution to journal › Article › peer-review

Lanza, F, Saraceni, F, Pezzi, A, Martino, M, Bosi, A, Cascavilla, N, Musto, P, Zuffa, E, Tani, M, Cellini, C, Laszlo, D, Bonifazi, F & Transplantation), OBOGITMO 2017, 'A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach', American Journal of Hematology, vol. 92, no. 9, pp. E557-E559. https://doi.org/10.1002/ajh.24817

@article{21a03fd542464e2da09fe094d7e8481a,

title = "A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach",

author = "F. Lanza and F. Saraceni and A. Pezzi and M. Martino and A. Bosi and N. Cascavilla and P. Musto and E. Zuffa and M. Tani and C. Cellini and D. Laszlo and F. Bonifazi and Transplantation), {on behalf of GITMO (Italian Society for}",

note = "Cited By :4 Export Date: 6 March 2018 CODEN: AJHED Correspondence Address: Lanza, F.; Unit, Ravenna HospitalItaly; email: francesco.lanza@auslromagna.it",

year = "2017",

doi = "10.1002/ajh.24817",

language = "English",

volume = "92",

pages = "E557--E559",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "9",

}

TY - JOUR

T1 - A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

AU - Lanza, F.

AU - Saraceni, F.

AU - Pezzi, A.

AU - Martino, M.

AU - Bosi, A.

AU - Cascavilla, N.

AU - Musto, P.

AU - Zuffa, E.

AU - Tani, M.

AU - Cellini, C.

AU - Laszlo, D.

AU - Bonifazi, F.

AU - Transplantation), on behalf of GITMO (Italian Society for

N1 - Cited By :4 Export Date: 6 March 2018 CODEN: AJHED Correspondence Address: Lanza, F.; Unit, Ravenna HospitalItaly; email: francesco.lanza@auslromagna.it

PY - 2017

Y1 - 2017

U2 - 10.1002/ajh.24817

DO - 10.1002/ajh.24817

M3 - Article

VL - 92

SP - E557-E559

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 9

ER -